Medilines Distributors Incorporated (PSE:MEDIC)
Philippines · Delayed Price · Currency is PHP 0.2100
+0.0070 (3.45%)
At close: Jun 22, 2026
Medilines Distributors Income Statement
Financials in millions PHP. Fiscal year is January - December.
Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,393 | 1,242 | 1,447 | 731.61 | 1,965 | 1,585 | |
Revenue Growth (YoY) | 4.24% | -14.16% | 97.78% | -62.76% | 23.96% | 8.07% |
Cost of Revenue | 1,045 | 935.93 | 1,031 | 482.04 | 1,581 | 1,253 |
Gross Profit | 347.32 | 306.2 | 416.14 | 249.57 | 383.33 | 332.16 |
Selling, General & Admin | 208.24 | 200.81 | 175.97 | 138.06 | 123.6 | 101.65 |
Operating Expenses | 250.28 | 242.85 | 229.77 | 137.77 | 124.8 | 126.12 |
Operating Income | 97.04 | 63.35 | 186.37 | 111.8 | 258.52 | 206.04 |
Interest Expense | -22.3 | -17.73 | -16.85 | -13.52 | -9.2 | -47.4 |
Interest & Investment Income | 0.1 | 0.09 | 0.08 | 0.1 | 0.25 | 25.6 |
Currency Exchange Gain (Loss) | 2.26 | 2.25 | -1.49 | -13.38 | -23.44 | -0.85 |
Other Non Operating Income (Expenses) | 25.27 | 12.81 | 17.15 | 19.14 | 30.77 | -1.24 |
EBT Excluding Unusual Items | 102.37 | 60.77 | 185.26 | 104.14 | 256.9 | 182.15 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 28.89 |
Other Unusual Items | - | - | - | - | - | -1.17 |
Pretax Income | 102.37 | 60.77 | 185.26 | 104.14 | 256.9 | 209.88 |
Income Tax Expense | 31.6 | 21.36 | 43.25 | 25.03 | 64.93 | 40.24 |
Net Income | 70.77 | 39.41 | 142.01 | 79.11 | 191.97 | 169.63 |
Net Income to Common | 70.77 | 39.41 | 142.01 | 79.11 | 191.97 | 169.63 |
Net Income Growth | -51.91% | -72.25% | 79.51% | -58.79% | 13.17% | 64.59% |
Shares Outstanding (Basic) | 2,493 | 2,747 | 2,747 | 2,748 | 2,750 | 1,896 |
Shares Outstanding (Diluted) | 2,493 | 2,747 | 2,747 | 2,748 | 2,750 | 1,896 |
Shares Change (YoY) | -21.65% | - | -0.05% | -0.08% | 45.05% | 18.49% |
EPS (Basic) | 0.03 | 0.01 | 0.05 | 0.03 | 0.07 | 0.09 |
EPS (Diluted) | 0.03 | 0.01 | 0.05 | 0.03 | 0.07 | 0.09 |
EPS Growth | -38.62% | -80.00% | 73.68% | -58.76% | -21.98% | 38.91% |
Free Cash Flow | 165.28 | 245.49 | 38.9 | -194.82 | -335.34 | 269.85 |
Free Cash Flow Per Share | 0.07 | 0.09 | 0.01 | -0.07 | -0.12 | 0.14 |
Dividend Per Share | - | - | 0.009 | 0.003 | 0.010 | 0.006 |
Dividend Growth | - | - | 261.54% | -75.19% | 71.80% | -96.17% |
Gross Margin | 24.94% | 24.65% | 28.76% | 34.11% | 19.51% | 20.96% |
Operating Margin | 6.97% | 5.10% | 12.88% | 15.28% | 13.16% | 13.00% |
Profit Margin | 5.08% | 3.17% | 9.81% | 10.81% | 9.77% | 10.70% |
Free Cash Flow Margin | 11.87% | 19.76% | 2.69% | -26.63% | -17.07% | 17.03% |
EBITDA | 117.53 | 81.98 | 198.28 | 124.65 | 268.08 | 216.18 |
EBITDA Margin | 8.44% | 6.60% | 13.70% | 17.04% | 13.64% | 13.64% |
D&A For EBITDA | 20.49 | 18.63 | 11.91 | 12.85 | 9.55 | 10.14 |
EBIT | 97.04 | 63.35 | 186.37 | 111.8 | 258.52 | 206.04 |
EBIT Margin | 6.97% | 5.10% | 12.88% | 15.28% | 13.16% | 13.00% |
Effective Tax Rate | 30.87% | 35.15% | 23.34% | 24.04% | 25.27% | 19.18% |
Advertising Expenses | - | 0.14 | 0.22 | 0.28 | 1.09 | 0.63 |